- $99.24m
- $68.35m
- $0.01m
Annual balance sheet for Genelux, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.3 | 4.5 | 0.397 | 23.2 | 30.9 |
| Prepaid Expenses | |||||
| Total Current Assets | 11.5 | 5.82 | 1.89 | 24.2 | 31.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.45 | 2.21 | 1.98 | 3.6 | 3.08 |
| Other Long Term Assets | |||||
| Total Assets | 14 | 8.13 | 5.53 | 27.9 | 34.7 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14.5 | 22.5 | 31.6 | 6.55 | 6.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 36.7 | 41.2 | 41.3 | 8.42 | 8.44 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -22.7 | -33.1 | -35.8 | 19.5 | 26.3 |
| Total Liabilities & Shareholders' Equity | 14 | 8.13 | 5.53 | 27.9 | 34.7 |
| Total Common Shares Outstanding |